SEC 13F Intelligence

Davis Selected Advisers / CVS

Davis Selected Advisers’s Cvs Health Corp Position

Does Davis Selected Advisers own Cvs Health Corp (CVS)? Yes12.24M shares worth $879M (+4.04% of its 13F portfolio) as of Q1 2026, down from 12.76M shares the prior filed quarter.

Position Value
$879M
Q1 2026
Shares
12.24M
% of Portfolio
+4.04%
Quarters Held
30
currently held

Position History CVS

Reported value by quarter
Q4 ’18: $74MQ4 ’18Q1 ’19: $61MQ2 ’19: $60MQ3 ’19: $67MQ4 ’19: $60MQ4 ’19Q1 ’20: $48MQ2 ’20: $53MQ3 ’20: $47MQ4 ’20: $54MQ4 ’20Q1 ’21: $59MQ2 ’21: $65MQ3 ’21: $66MQ4 ’21: $22MQ4 ’21Q1 ’22: $21MQ2 ’22: $19MQ3 ’22: $20MQ4 ’22: $19MQ4 ’22Q1 ’23: $15MQ2 ’23: $14MQ3 ’23: $14MQ4 ’23: $16MQ4 ’23Q1 ’24: $14MQ2 ’24: $22MQ3 ’24: $23MQ4 ’24: $511MQ4 ’24Q1 ’25: $782MQ2 ’25: $799MQ3 ’25: $860MQ4 ’25: $1.0BQ4 ’25Q1 ’26: $879Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202612.24M$879M+4.04%
Q4 202512.76M$1.0B+4.55%
Q3 202511.40M$860M+4.49%
Q2 202511.59M$799M+4.27%
Q1 202511.55M$782M+4.51%
Q4 202411.39M$511M+2.97%
Q3 2024367.5K$23M+0.13%
Q2 2024364.8K$22M+0.13%
Q1 2024172.7K$14M+0.08%
Q4 2023206.4K$16M+0.09%
Q3 2023204.6K$14M+0.09%
Q2 2023207.8K$14M+0.09%
Q1 2023207.9K$15M+0.10%
Q4 2022208.1K$19M+0.13%
Q3 2022207.4K$20M+0.14%
Q2 2022208.3K$19M+0.12%
Q1 2022208.4K$21M+0.11%
Q4 2021213.7K$22M+0.10%
Q3 2021779.2K$66M+0.31%
Q2 2021780.4K$65M+0.27%
Q1 2021781.3K$59M+0.26%
Q4 2020791.4K$54M+0.26%
Q3 2020798.2K$47M+0.26%
Q2 2020812.6K$53M+0.31%
Q1 2020804.6K$48M+0.32%
Q4 2019812.3K$60M+0.29%
Q3 20191.07M$67M+0.34%
Q2 20191.10M$60M+0.30%
Q1 20191.12M$61M+0.30%
Q4 20181.13M$74M+0.41%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Davis Selected Advisers’s full portfolio or all institutional holders of CVS.